The latest news in cancer research, health and policy by Cancer Research UK.
We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy.
Children in England with high-risk neuroblastoma will now be offered a cancer drug that could extend their life.
A researcher explains an early stage clinical trial testing the potential of a new type of immunotherapy to treat neuroblastoma.
A number of cancer clinical trials involving immunotherapy treatments appear to be showing promise, according to new research.
Like a horde of microscopic cellular superheroes, each with unique superpowers, your body’s immune system is made up of many different types of cells, all working together...
Cancer cells in neuroblastoma release a molecule that breaks down a key energy source for the body’s immune cells, leaving them too drained to fight the disease
How the Pill affects cancer risk, making tumours more sensitive to treatment, and fighting cancer with physics.
A simple blood test could pinpoint which children are unlikely to respond to treatment for a particularly aggressive form of neuroblastoma
A new study has shed light on the genetic causes of neuroblastoma, a rare but aggressive childhood cancer that affects around 100 children a year in the UK.
US scientists have discovered genetic faults that appear to be behind the majority of inherited cases of the childhood cancer neuroblastoma.